Petmed Express Stock Alpha and Beta Analysis

PETS Stock  USD 5.73  1.51  35.78%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as PetMed Express. It also helps investors analyze the systematic and unsystematic risks associated with investing in PetMed Express over a specified time horizon. Remember, high PetMed Express' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to PetMed Express' market risk premium analysis include:
Beta
0.59
Alpha
0.91
Risk
5.33
Sharpe Ratio
0.22
Expected Return
1.19
Please note that although PetMed Express alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, PetMed Express did 0.91  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of PetMed Express stock's relative risk over its benchmark. PetMed Express has a beta of 0.59  . As returns on the market increase, PetMed Express' returns are expected to increase less than the market. However, during the bear market, the loss of holding PetMed Express is expected to be smaller as well. At this time, PetMed Express' Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 464.80 in 2024, whereas Book Value Per Share is likely to drop 2.81 in 2024.

Enterprise Value

39.53 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out PetMed Express Backtesting, PetMed Express Valuation, PetMed Express Correlation, PetMed Express Hype Analysis, PetMed Express Volatility, PetMed Express History and analyze PetMed Express Performance.
For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.

PetMed Express Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. PetMed Express market risk premium is the additional return an investor will receive from holding PetMed Express long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in PetMed Express. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate PetMed Express' performance over market.
α0.91   β0.59

PetMed Express expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of PetMed Express' Buy-and-hold return. Our buy-and-hold chart shows how PetMed Express performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

PetMed Express Market Price Analysis

Market price analysis indicators help investors to evaluate how PetMed Express stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PetMed Express shares will generate the highest return on investment. By understating and applying PetMed Express stock market price indicators, traders can identify PetMed Express position entry and exit signals to maximize returns.

PetMed Express Return and Market Media

The median price of PetMed Express for the period between Sat, Aug 10, 2024 and Fri, Nov 8, 2024 is 3.64 with a coefficient of variation of 12.87. The daily time series for the period is distributed with a sample standard deviation of 0.47, arithmetic mean of 3.64, and mean deviation of 0.37. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of 601 shares by Jacqueline Smith of PetMed Express at 3.19 subject to Rule 16b-3
08/15/2024
2
PetMed Express taps Robyn DElia as finance chief
09/12/2024
3
Insider Trading
09/26/2024
4
Acquisition by Delia Robyn M. of 250000 shares of PetMed Express subject to Rule 16b-3
09/27/2024
5
PetMed Express, Inc. Sets Fiscal Second Quarter 2025 Earnings Call
10/24/2024
6
What To Expect From PetMed Express Inc Q2 2025 Earnings
11/05/2024
7
PetMed Express, Inc. to Participate in the Sidoti Micro Cap Conference
11/07/2024

About PetMed Express Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including PetMed or other stocks. Alpha measures the amount that position in PetMed Express has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Dividend Yield0.04680.07450.130.14
Price To Sales Ratio1.91.280.340.32

PetMed Express Upcoming Company Events

As portrayed in its financial statements, the presentation of PetMed Express' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PetMed Express' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of PetMed Express' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of PetMed Express. Please utilize our Beneish M Score to check the likelihood of PetMed Express' management manipulating its earnings.
5th of February 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of May 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View

Build Portfolio with PetMed Express

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for PetMed Stock Analysis

When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.